Page 3 - ஒழுங்குமுறை சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒழுங்குமுறை சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒழுங்குமுறை சிகிச்சை Today - Breaking & Trending Today

Earnings Scheduled For May 13, 2021

Companies Reporting Before The Bell
• CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of . ....

New York , United States , Laird Superfood , Butterfly Network , Goodrx Holdings , Sotera Health , Spectrum Pharmaceuticals , Research Solutions , Motorola Solutions , Marinus Pharmaceuticals , Viant Technology , Zepp Health , Oscar Health , Frontier Group Holdings , Energy Focus , Celsius Holdings , Infinity Pharmaceuticals , Hydrofarm Holdings Group , Inmed Pharmaceuticals , Lucira Health , Fathom Holdings , Senseonics Holdings , National Vision Holdings , Pf Industries , Kingstone Companies , Onesmart Intl Edu Group ,

Regulus: Q1 Earnings Snapshot

Regulus: Q1 Earnings Snapshot
Last Updated May 13, 2021 at 4:28 pm EDT
SAN DIEGO (AP) Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $6 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of 8 cents.
In the final minutes of trading on Thursday, the company’s shares hit 82 cents. A year ago, they were trading at 67 cents.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS
The Associated Press
Updated Today at 02:56 AM ....

Regulus Therapeutics Inc , Zacks Investment Research , Associated Press , Regulus Therapeutics , San Diego Based , Automated Insights , Zacks Investment , ஒழுங்குமுறை சிகிச்சை இன்க் , ஜாக்கக்ஸ் முதலீடு ஆராய்ச்சி , தொடர்புடையது ப்ரெஸ் , ஒழுங்குமுறை சிகிச்சை , சான் டியாகோ அடிப்படையிலானது , தானியங்கி நுண்ணறிவு , ஜாக்கக்ஸ் முதலீடு ,

Regulus Therapeutics, Inc. to Host Earnings Call

Regulus Therapeutics, Inc. to Host Earnings Call
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Regulus Therapeutics , Earnings Results , Investor Network , ஒழுங்குமுறை சிகிச்சை ,

January Therapeutics today announced the appointment of Dr. Paul Grint to the Board of Directors

January Therapeutics today announced the appointment of Dr. Paul Grint to the Board of Directors
Share Article
Dr. Paul Grint is bringing his experience as CMO, CEO (Private & Public Companies), Chairman of the Board, and Board Member to help January s Board
SAN DIEGO (PRWEB)
May 05, 2021
Dr. Grint has served as the Executive Chairman of the Board of Directors of Cardea Bio since April 2020. He also has served as a member of the Board of Directors and as a member of the compensation committee of Amplyx Pharmaceuticals, Inhibikase Therapeutics and Synedgen.
From 2017 to 2019, Dr. Grint served as Chief Executive Officer of AmpliPhi Biosciences and as a member of AmpliPhi Bioscience’s Board of Directors from 2015 to 2019, additionally from 2014 to 2017 Dr. Grint served as Chief Executive Officer of Regulus Therapeutics, Inc., both publicly traded clinical stage biopharmaceutical companies. ....

Ampliphi Biosciences , Cardea Bio , Sam Ellis , Bartholomew Hospital College , Regulus Therapeutics Inc , Mary Hospital College , Amplyx Pharmaceuticals , University Of London , Royal College Of Pathologists , Plough Corporation , Executive Chairman , Inhibikase Therapeutics , Chief Executive Officer , Ampliphi Bioscience , Regulus Therapeutics , Forest Laboratories , Royal College , Hospital College , Press Release , கார்டியா உயிர் , சாம் நீள்வட்டம் , ஒழுங்குமுறை சிகிச்சை இன்க் , பல்கலைக்கழகம் ஆஃப் லண்டன் , அரச கல்லூரி ஆஃப் நோயியல் நிபுணர்கள் , ப்லௌ நிறுவனம் , நிர்வாகி தலைவர் ,

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday s After-Market Session
Gainers
Obalon Therapeutics (NASDAQ:OBLN) stock moved upwards by 7.75% to $2.64 during Tuesday’s after-market session. Obalon Therapeutics’s trading volume hit 1.0K shares by close, accounting for 0.08% of its average volume over the last 100 days. The company’s market cap stands at $26.4 million.
Organogenesis Holdings (NASDAQ:ORGO) shares rose 7.35% to $22.48. At the close, Organogenesis Holdings’s trading volume reached 25.1K shares. This is 3.3% of its average volume over the last 100 days. The company’s market cap stands at $2.8 billion.
Xenetic Biosciences (NASDAQ:XBIO) stock increased by 7.21% to $2.08. Xenetic Biosciences’s trading volume hit 4.6K shares by close, accounting for 1.43% of its average volume over the last 100 days. The market value of their outstanding shares is at $18.1 million. ....

Xenetic Biosciences , Organogenesis Holdings , Adamis Pharmaceuticals , Infinity Pharmaceuticals , Regulus Therapeutics , முடிவிலி மருந்துகள் , ஒழுங்குமுறை சிகிச்சை ,